High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored? (Q42969686)

11 November 2017

High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored? (English)

1 reference

11 November 2017

Amit A Lugade

1 reference

11 November 2017

Suresh Kalathil

1 reference

11 November 2017

Austin Miller

1 reference

11 November 2017

Renuka Iyer

1 reference

11 November 2017

Yasmin Thanavala

1 reference

11 November 2017

30 April 2013

1 reference

11 November 2017

1 reference

11 November 2017

1 reference

11 November 2017

1 reference

11 November 2017

e24679

1 reference

Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality

11 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782165

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782165

CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782165

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782165

FOXP3 defines regulatory T cells in human tumor and autoimmune disease

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782165

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782165

Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782165

Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3782165

Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24073364

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24073364

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/ONCI.24679

1 reference

11 November 2017

1 reference

11 November 2017

PubMed publication ID

24073364

1 reference